Suppr超能文献

难治性高血压与慢性肾脏病:一种危险的关联

Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.

作者信息

Wolley Martin J, Stowasser Michael

机构信息

Endocrine Hypertension Research Centre, Greenslopes and Princess Alexandra Hospitals, University of Queensland School of Medicine, Ipswich Road, Woolloongabba, Brisbane, 4102, Australia.

Department of Nephrology, Royal Brisbane and Women's Hospital, Brisbane, Australia.

出版信息

Curr Hypertens Rep. 2016 Apr;18(5):36. doi: 10.1007/s11906-016-0641-x.

Abstract

Treatment-resistant hypertension is an increasingly recognised problem and is markedly over-represented in patients with chronic kidney disease (CKD). Recent evidence has clarified the heightened risk for both adverse renal and cardiovascular outcomes associated with resistant hypertension, even when blood pressure control is attained. The diagnosis of resistant hypertension in CKD is reliant on accurate blood pressure measurement, and out of office measurements are important due to the high prevalence of masked hypertension in these patients. Treatment strategies include careful dietary measures to restrict sodium intake, and a focus on improving adherence to antihypertensive medications. Medication choices should focus on a sensible foundation and then diuretic titration to combat the salt and volume retention inherent in CKD. In this review, we discuss the epidemiology, pathogenesis and consequences of resistant hypertension in CKD, and then review the optimal diagnostic and management strategies.

摘要

难治性高血压是一个日益受到认可的问题,在慢性肾脏病(CKD)患者中显著多见。近期证据表明,即使血压得到控制,难治性高血压与不良肾脏和心血管结局的风险仍会增加。CKD患者难治性高血压的诊断依赖于准确的血压测量,由于这些患者中隐匿性高血压的患病率很高,诊室外测量很重要。治疗策略包括谨慎的饮食措施以限制钠摄入,并注重提高对抗高血压药物的依从性。药物选择应基于合理的基础,然后进行利尿剂滴定以对抗CKD固有的盐和容量潴留。在本综述中,我们讨论了CKD患者难治性高血压的流行病学、发病机制和后果,然后回顾了最佳诊断和管理策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验